Recherche
-
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
Axo-axonic cells in neuropsychiatric disorders: a systematic review.
(Frontiers in Cellular Neuroscience. vol. 17, 2023-06-26)Article de revueLibre accès -
Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry
(International Journal of Molecular Sciences. vol. 24, n° 11, 2023-06-02)Article de revueLibre accès -
Yin-Yang control of energy balance by lipids in the hypothalamus: The endocannabinoids vs bile acids case
(Biochimie, 2022)Article de revueLibre accès -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
(Science Advances. vol. 6, n° 20, 2020-05-13)Article de revueLibre accès -
GnRH replacement rescues cognition in Down syndrome
(2022)Document de travail - Pré-publicationLibre accès -
The CB1 cannabinoid receptor regulates autophagy in the tibialis anterior skeletal muscle in mice
(Biological Research. vol. 56, n° 1, pp. 14, 2023-03-25)Article de revueLibre accès -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès -
Metabolic Messengers: endocannabinoids
(2022)Document de travail - Pré-publicationLibre accès -
Forgetting in obesity: The pregnenolone link
(2022)Document de travail - Pré-publicationLibre accès